期刊文献+

冠状动脉内支架置入后再狭窄的临床危险因素探讨 被引量:1

Clinic study of coronary stent restenosis
原文传递
导出
摘要 目的 :探讨临床因素对冠状动脉 (冠脉 )内支架置入后再狭窄的影响。方法 :选择成功施行冠脉支架置入并进行临床和血管造影随访的 78例冠心病患者。按造影结果分为再狭窄组 (n =4 9)和无再狭窄组 (n=2 9)。比较支架置入前临床资料 ,应用单因素和多因素回归分析法分析术前临床危险因素与再狭窄的相关性。结果 :多因素逐步回归分析认为 ,患者术前的不稳定型心绞痛 (UA)是再狭窄形成的独立危险因素 (P <0 .0 5 ,OR :3.0 93)。结论 :临床因素与预后有关 ,UA是介入治疗预后和再狭窄发生的重要影响因子。 Objective: To investigate the relation between coronary stent restenosis and clinic factors. Method: Seventy eight patients with coronary stenting were classified into restenosis group and non restenosis group by angiography after coronary stent placement 4~6 months. Relationship between restenosis and some clinical factors was studied using univariate and multivariate analysis. Result: Logistic regression analysis revealed that unstable angina was associated with restenosis after stenting. (P< 0.05 , OR: 3.093 ).Conclusion:Unstable angina is related with stent restenosis.
出处 《临床心血管病杂志》 CAS CSCD 北大核心 2002年第6期260-261,共2页 Journal of Clinical Cardiology
关键词 冠状动脉内支架置入 再狭窄 危险因素 冠状动脉疾病 Coronary disease Stent Risk factors Restenosis
  • 相关文献

参考文献2

二级参考文献1

共引文献2718

同被引文献7

  • 1金泽宁,陈韵岱,吕树铮,宋现涛,朱华刚,李红.冠心病合并糖尿病患者金属裸支架置入术后再狭窄的临床和造影预测因素[J].中华心血管病杂志,2006,34(12):1093-1096. 被引量:11
  • 2D'Ascenzo F, Bollati M, Quadri G, et al. Appraising failure of surgical and percutaneous revascularization: longtermoutcomes from an observational registry[ J]. Minerva Cardioangiol,2013, 61 (6) :675 -681.
  • 3Deftereos S, Giannopoulos G, Raisakis K, et al. Colchicine treat- ment for the prevention of bare - metal stent restenosis in dia- betic patients[J]. J Am Coil Cardiol,2013,61 (16) :1679 - 1685.
  • 4Lee HW, Lee HC, Kim BW, et al. Effects of lowdosepioglitazone on restenosis and coronaryatherosclerosis in diabetic patients undergoing drug eluting stent implantation [ J ]. Yonsei Med J, 2013,54(6) :1313 - 1320.
  • 5Spadaccio C, Patti G, De Marco F, et al. Usefulness of preproce- dural levels of advanced glycation end products to predict rest- enosis in patients with controlled diabetes mellitus undergoing drug - eluting stent implantation for stable angina pectoris (from the Prospective ARMYDA - AGEs Study) [ J ]. Am J Cardiol.2013.112( 1 ) :21 -26.
  • 6Vardi M, Burke DA, Bangalore S, et al. Long - term efficacy and safety of Zotarolimus - eluting stent in patients with diabetes mellitus : pooled 5 - year results from the ENDEAVOR Ⅲ and Ⅳ trlals[J]. Catheter Cardiovasc Interv,2013,82(7) :1031 -1038.
  • 7Takagi T, Okura H, Kobayashi Y, et al. A prospective, multi- center,randomized trial to assess efficacy of pioglitazone on in -stent neointimal suppression in type 2 diabetes: POPPS ( Prevention of In - Stent Neointimal Proliferation by Pioglita-zone Study) [ J ]. JACC Cardiovasc Interv, 2009,2 ( 6 ) : 524 - 531.

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部